These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7990963)

  • 1. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
    Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
    Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
    J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
    Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
    Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Grenier L; Llinas-Brunet M; Plante R
    J Med Chem; 1995 Sep; 38(18):3617-23. PubMed ID: 7658449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleotide reductase inhibitors as anti-herpes agents.
    Wnuk SF; Robins MJ
    Antiviral Res; 2006 Sep; 71(2-3):122-6. PubMed ID: 16621038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
    Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
    Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase.
    Liuzzi M; Kibler P; Bousquet C; Harji F; Bolger G; Garneau M; Lapeyre N; McCollum RS; Faucher AM; Simoneau B; Cordingley MG
    Antiviral Res; 2004 Dec; 64(3):161-70. PubMed ID: 15550269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
    Brandt CR; Spencer B; Imesch P; Garneau M; Déziel R
    Antimicrob Agents Chemother; 1996 May; 40(5):1078-84. PubMed ID: 8723444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
    Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
    Lamarche N; Gaudreau P; Massie B; Langelier Y
    Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
    Krogsrud RL; Welchner E; Scouten E; Liuzzi M
    Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
    Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
    J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
    Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
    Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2.
    Cohen EA; Gaudreau P; Brazeau P; Langelier Y
    Nature; 1986 May 22-28; 321(6068):441-3. PubMed ID: 3012360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.